DowDuPont’s $12 Billion of Credit Facilities
November 20, 2018
Cravath represented JPMorgan Chase Bank, N.A., as administrative agent and lead arranger, in connection with the arrangement of $12 billion of credit facilities made available to DowDuPont Inc. and its soon to be spun‑off subsidiary Corteva. This transaction is in connection with DowDuPont’s announced separation into three public companies. The facilities consisted of a $3 billion five‑year revolving credit facility, a $3 billion three‑year revolving credit facility, a $3 billion revolving credit facility and a $3 billion term loan facility. The transaction closed on November 12, 2018.
The Cravath team included partner Tatiana Lapushchik, senior attorney Kimberly A. Grousset and associates Matthew S. Weiner and Michael W. Fahner on banking matters, and associate Damien J. Rose on tax matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 2000, Harvard Law Schoolcum laude
-
B.A., 1997, Barnard Collegesumma cum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
February 20, 2026
First Solar’s $1.5 Billion Revolving Credit Facility
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 08, 2026
Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
Deals & Cases
December 24, 2025
Ameren’s $3.2 Billion of Revolving Credit Facilities
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $3.2 billion of revolving credit facilities made available to Ameren Corporation and Union Electric Company (the “Missouri Borrowers”) and Ameren Corporation and Ameren Illinois Company (the “Illinois Borrowers”). Ameren Corporation is an American power company that engages in the rate‑regulated electric generation, transmission and distribution activities; and rate‑regulated natural gas distribution and transmission businesses. The facilities consisted of a $1.9 billion revolving credit facility (Missouri Borrowers) and $1.3 billion revolving credit facility (Illinois Borrowers). The transaction closed on December 10, 2025.
Deals & Cases
November 24, 2025
Thomson Reuters Corporation’s $2 Billion Revolving Credit Facility
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $2 billion revolving credit facility made available to Thomson Reuters Corporation, a leading AI and technology company empowering professionals with trusted content and workflow automation. The transaction closed on November 10, 2025.
